References
- Li D, Phusanti L, Desai DS. (2007). Antidiabetic formulation and method. US Patent 7183321.
- Tripathi KD. (2004). Essentials of Medical Pharmacology. Jaypee Brothers Medical Publishers Pvt. Ltd., New Delhi, India, pp. 235–253.
- Riddle M. (2000). Combining sulfonylureas and other oral agents. Am J Med, 108 (Suppl 6a):15S–22S.
- Dashora K, Saraf S. (2006). Multi-component drug delivery system: an emerging trend. Express Pharma, 7:1–15.
- Balan G, Timmins P, Greene DS, Marathe PH. (2001). In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers. J Pharmaceutical Sciences, 90:1176–1185.
- Defang O, Shufang N, Wei L, Hong G, Hui L, Weisan P. (2005). In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide. Drug Dev Ind Pharm, 31:677–685.
- Lachman L, Liberman HA. (1990). Pharmaceutical Dosage Form-Tablet, 2nd ed. Marcel Dekker, New York, pp. 273–274.
- Patel RB, Patel RP, Patel MM. (2010). Development of an osmotically controlled drug delivery system of glipizide. Pharm Technol, 34:80–91.
- Matharu. (2003). Pharmaceutical composition. US Patent 20030021841.
- Li XD, Pan WS, Nie SF, Wu LJ. (2004). Studies on controlled release effervescent osmotic pump tablet from traditional Chinese medicinal compound recipe. J Control Release, 96:359–367.